Louise SILVESTRE

Person

Paris, FR

People

Patents Grantslast 30 patents

Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 12,186,374
- Issue date Jan 7, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 11,026,999
- Issue date Jun 8, 2021
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of AVE0010 for the treatment of diabetes mellitus type 2
- Patent number 9,981,013
- Issue date May 29, 2018
- Sanofi-Aventis Deutschland GmbH
- Gabor Boka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Insulin glargine/lixisenatide fixed ratio formulation
- Patent number 9,950,039
- Issue date Apr 24, 2018
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combination for improving glycemic control as add-on...
- Patent number 9,821,032
- Issue date Nov 21, 2017
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Niemoeller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical combination for use in glycemic control in diabetes...
- Patent number 9,408,893
- Issue date Aug 9, 2016
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Niemöeller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method for improving glucose tolerance in a diabetes type 2 patient...
- Patent number 8,735,349
- Issue date May 27, 2014
- Sanofi-Aventis Deutschland GmbH
- Louise Silvestre
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20250177487
- Publication date Jun 5, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD FOR INDUCING WEIGHT LOSS IN A TYPE 2 DIABETES MELLITUS PATIENT
- Publication number 20250134964
- Publication date May 1, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMÖELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20250064898
- Publication date Feb 27, 2025
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20230037934
- Publication date Feb 9, 2023
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...
- Publication number 20230028588
- Publication date Jan 26, 2023
- SANOFI-AVENTIS DEUTSCHLAND GMBH
- Elisabeth NIEMOELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...
- Publication number 20220347269
- Publication date Nov 3, 2022
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMÖELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMEN...
- Publication number 20220054594
- Publication date Feb 24, 2022
- Sanofi-Aventis Deutschland GmbH
- Gabor Boka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20220031811
- Publication date Feb 3, 2022
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20210128692
- Publication date May 6, 2021
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AVE0010 FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2
- Publication number 20200353054
- Publication date Nov 12, 2020
- Sanofi-Aventis Deutschland GmbH
- Gabor Boka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...
- Publication number 20200338171
- Publication date Oct 29, 2020
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMÖELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...
- Publication number 20200330559
- Publication date Oct 22, 2020
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMOELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20200038488
- Publication date Feb 6, 2020
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION
- Publication number 20190381145
- Publication date Dec 19, 2019
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Combination for Use in Glycemic Control in Diabetes...
- Publication number 20190134160
- Publication date May 9, 2019
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMOELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin Glargine/Lixisenatide Fixed Ratio Formulation
- Publication number 20190060411
- Publication date Feb 28, 2019
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
- Publication number 20190054146
- Publication date Feb 21, 2019
- Sanofi-Aventis Deutschland GmbH
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of AVE0010 for the Treatment of Diabetes Mellitus Type 2
- Publication number 20190030132
- Publication date Jan 31, 2019
- Sanofi-Aventis Deutschland GmbH
- Gabor Boka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...
- Publication number 20180339023
- Publication date Nov 29, 2018
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMÖELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20180133290
- Publication date May 17, 2018
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
- Publication number 20180000902
- Publication date Jan 4, 2018
- Sanofi-Aventis Deutschland GmbH
- Gabor BOKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Pharmaceutical Combination for Use in Glycemic Control in Diabetes...
- Publication number 20170143801
- Publication date May 25, 2017
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMOELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...
- Publication number 20170136094
- Publication date May 18, 2017
- Sanofi-Aventis Deutschland GmbH
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AVE0010 FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2
- Publication number 20170119852
- Publication date May 4, 2017
- Sanofi-Aventis Deutschland GmbH
- Gabor BOKA
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS
- Publication number 20170080057
- Publication date Mar 23, 2017
- Sanofi-Aventis Deutschland GmbH
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20160199452
- Publication date Jul 14, 2016
- Sanofi-Aventis Deutschland GmbH
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Insulin glargine/lixisenatide fixed ratio formulation
- Publication number 20140371141
- Publication date Dec 18, 2014
- Elisabeth Souhami
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMEN...
- Publication number 20140148384
- Publication date May 29, 2014
- Sanofi-Aventis Deutschland GmbH
- Gabor Boka
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT PROTOCOL OF DIABETES TYPE 2
- Publication number 20130296236
- Publication date Nov 7, 2013
- Louise SILVESTRE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...
- Publication number 20130203666
- Publication date Aug 8, 2013
- Sanofi-Aventis Deutschland GmbH
- Elisabeth NIEMOELLER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Louise SILVESTRE

Person

Patents Grantslast 30 patents

Insulin glargine/lixisenatide fixed ratio formulation

Insulin glargine/lixisenatide fixed ratio formulation

Use of AVE0010 for the treatment of diabetes mellitus type 2

Insulin glargine/lixisenatide fixed ratio formulation

Pharmaceutical combination for improving glycemic control as add-on...

Pharmaceutical combination for use in glycemic control in diabetes...

Method for improving glucose tolerance in a diabetes type 2 patient...

Patents Applicationslast 30 patents

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

METHOD FOR INDUCING WEIGHT LOSS IN A TYPE 2 DIABETES MELLITUS PATIENT

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...

PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...

USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMEN...

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

USE OF AVE0010 FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2

PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...

PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

INSULIN GLARGINE/LIXISENATIDE FIXED RATIO FORMULATION

Pharmaceutical Combination for Use in Glycemic Control in Diabetes...

Insulin Glargine/Lixisenatide Fixed Ratio Formulation

PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

Use of AVE0010 for the Treatment of Diabetes Mellitus Type 2

PHARMACEUTICAL COMBINATION FOR IMPROVING GLYCEMIC CONTROL AS ADD-ON...

Insulin glargine/lixisenatide fixed ratio formulation

PREVENTION OF HYPOGLYCAEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

Pharmaceutical Combination for Use in Glycemic Control in Diabetes...

METHOD OF TREATMENT OF DIABETES TYPE 2 COMPRISING ADD-ON THERAPY TO...

USE OF AVE0010 FOR THE TREATMENT OF DIABETES MELLITUS TYPE 2

PREVENTION OF HYPOGLYCEMIA IN DIABETES MELLITUS TYPE 2 PATIENTS

Insulin glargine/lixisenatide fixed ratio formulation

Insulin glargine/lixisenatide fixed ratio formulation

USE OF AVE0010 FOR THE MANUFACTURE OF A MEDICAMENT FOR THE TREATMEN...

TREATMENT PROTOCOL OF DIABETES TYPE 2

PHARMACEUTICAL COMBINATION FOR USE IN GLYCEMIC CONTROL IN DIABETES...